Showing results (1441-1450 of 2,669) with videos related to
Sort By:
Pageof 267
Oncology Research|June 15, 1999
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cellsF R Luo, S D Wyrick, S G ChaneyOncology Research|June 15, 1999
Hypothermia causes a reversible, p53-mediated cell cycle arrest in cultured fibroblastsZ Matijasevic, J E Snyder, D B LudlumOncology Research|August 18, 1999
Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesisA Bishayee, S Roy, M ChatterjeeOncology Research|August 18, 1999
Melanoma-inhibitory activity protein concentrations in blood of melanoma patients treated with immunotherapyD Dréau, A K Bosserhoff, R L White, et al.Oncology Research|May 25, 1999
Effect of local anesthetic ropivacaine on the energy metabolism of Ehrlich ascites tumor cellsM Di Padova, R Barbieri, M Fanciulli, et al.Oncology Research|May 25, 1999
An alpha2-macroglobulin-serine proteinase complex from human carcinomatous ascites and pleural effusion: isolation, monoclonal antibody preparation, and immunohistochemical studyK Arima, Y Nakamura, N Takami, et al.Oncology Research|September 17, 1999
BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC)D Shen, J V VadgamaOncology Research|May 1, 1999
Immunohistochemical detection of gastric mucin in normal and disease statesK L Taylor, A S Mall, R A Barnard, et al.Oncology Research|May 1, 1999
Infrequent p53 mutations in arsenic-related skin lesionsK Castrén, A Ranki, J A Welsh, et al.Oncology Research|January 1, 1995
A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agentsS Hashimoto, M K Danks, S Chatterjee, et al.Pageof 267